The latest announcement is out from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ). Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ... ( read original story ...)
Shanghai Dazhong Public Utilities Releases Q3 2025 Financial Results
Shanghai Dazhong Public Utilities (Group) Co., Ltd. Class H ( (HK:1635) ) just unveiled an announcement. ( read original story ...)
CXMT begins producing advanced LPDDR5X memory chips as China narrows tech gap
Mass production of LPDDR5X DRAM reflects the firm’s growing capabilities as it prepares for a Shanghai IPO amid intensifying competition. ( read original story ...)
China’s benchmark stock index surpasses 4,000 points in morning trade
VCG. China's benchmark Shanghai Composite Index briefly surpassed 4,000 points during trading on Tuesday morning, reaching its highest level since August 19, 20 ... ( read original story ...)
The 10 top-performing ETFs on SGX in Q3; China funds dominate
The rally was heavily concentrated in technology, growth, and A-share benchmarks Read more at The Business Times. ( read original story ...)
Everdisplay’s New Hong Kong IPO application – Investor Takeaways
Everdisplay is seeking funds from a Hong Kong IPO as it prepares to make the transition to flexible AMOLED displays; The company has posted steady revenue growth in ... ( read original story ...)
Shanghai Junshi Biosciences Reports Strong Q3 2025 Financial Performance
Shanghai Junshi Biosciences Co., Ltd. Class H ( ($HK:1877) ) has shared an announcement. Shanghai Junshi Biosciences Co., Ltd. has released its ... ( read original story ...)